基因检测在肿瘤精准药学中的意义(7)
[18] Ou SI, Ahn JS, De Petris L, et al. Alectinib in crizotinib- refractory ALK-rearranged non-small-cell lung cancer: a phase Ⅱ global study[J]. J Clin Oncol, 2016, 34(7): 661-668.[19] Shaw AT, Gan dhi L, Gadgeel S, et al. Alectinib in ALKpositive, crizotinib-resistant, non-small-cell lung cancer: a single-group ......
您现在查看是摘要页,全文长 2606 字符。